Applications of accelerator mass spectrometry for pharmacological and toxicological research

✍ Scribed by Karen Brown; Elaine M. Tompkins; Ian N.H. White

• Publisher: John Wiley and Sons
• Year: 2005
• Tongue: English
• Weight: 529 KB
• Volume: 25
• Category: Article
• ISSN: 0277-7037
• DOI: 10.1002/mas.20059

✦ Synopsis

Abstract

The technique of accelerator mass spectrometry (AMS), known for radiocarbon dating of archeological specimens, has revolutionized high‐sensitivity isotope detection in pharmacology and toxicology by allowing the direct determination of the amount of isotope in a sample rather than measuring its decay. It can quantify many isotopes, including ^26^Al, ^14^C, ^41^Ca, and ^3^H with detection down to attomole (10^−18^) amounts. Pharmacokinetic data in humans have been achieved with ultra‐low levels of radiolabel. One of the most exciting biomedical applications of AMS with ^14^C‐labeled potential carcinogens is the detection of modified proteins or DNA in tissues. The relationship between low‐level exposure and covalent binding of genotoxic chemicals has been compared in rodents and humans. Such compounds include heterocyclic amines, benzene, and tamoxifen. Other applications range from measuring the absorption of ^26^Al to monitoring ^41^Ca turnover in bone. In epoxy‐embedded tissue sections, high‐resolution imaging of ^14^C label in cells is possible. The uses of AMS are becoming more widespread with the availability of instrumentation dedicated to the analysis of biomedical samples. © 2005 Wiley Periodicals, Inc.